These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19146996)

  • 1. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications.
    Hamada Y; Fujii H; Kitazawa R; Yodoi J; Kitazawa S; Fukagawa M
    Bone; 2009 May; 44(5):936-41. PubMed ID: 19146996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
    Hamada Y; Kitazawa S; Kitazawa R; Fujii H; Kasuga M; Fukagawa M
    Bone; 2007 May; 40(5):1408-14. PubMed ID: 17251074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy.
    Kamimoto Y; Sugiyama T; Kihira T; Zhang L; Murabayashi N; Umekawa T; Nagao K; Ma N; Toyoda N; Yodoi J; Sagawa N
    Diabetologia; 2010 Sep; 53(9):2046-55. PubMed ID: 20512310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin-1 attenuates early graft loss after intraportal islet transplantation in mice.
    Asami K; Inagaki A; Imura T; Sekiguchi S; Fujimori K; Masutani H; Yodoi J; Satomi S; Ohuchi N; Goto M
    PLoS One; 2013; 8(8):e70259. PubMed ID: 23950917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.
    Hamada Y; Kitazawa S; Kitazawa R; Kono K; Goto S; Komaba H; Fujii H; Yamamoto Y; Yamamoto H; Usami M; Fukagawa M
    Endocrine; 2010 Dec; 38(3):369-76. PubMed ID: 20972729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.
    Hamada Y; Miyata S; Nii-Kono T; Kitazawa R; Kitazawa S; Higo S; Fukunaga M; Ueyama S; Nakamura H; Yodoi J; Fukagawa M; Kasuga M
    Nephrol Dial Transplant; 2007 Jun; 22(6):1547-57. PubMed ID: 17360766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis.
    Xie H; Wang Q; Zhang X; Wang T; Hu W; Manicum T; Chen H; Sun L
    Biomed Pharmacother; 2018 Dec; 108():280-287. PubMed ID: 30223099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin, an anti-oxidant protein, protects mouse embryos from oxidative stress-induced developmental anomalies.
    Kobayashi-Miura M; Nakamura H; Yodoi J; Shiota K
    Free Radic Res; 2002 Sep; 36(9):949-56. PubMed ID: 12448820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin overexpression in mice, model of attenuation of oxidative stress, prevents benzene-induced hemato-lymphoid toxicity and thymic lymphoma.
    Li GX; Hirabayashi Y; Yoon BI; Kawasaki Y; Tsuboi I; Kodama Y; Kurokawa Y; Yodoi J; Kanno J; Inoue T
    Exp Hematol; 2006 Dec; 34(12):1687-97. PubMed ID: 17157166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1.
    Kawasaki K; Nishio A; Nakamura H; Uchida K; Fukui T; Ohana M; Yoshizawa H; Ohashi S; Tamaki H; Matsuura M; Asada M; Nishi T; Nakase H; Toyokuni S; Liu W; Yodoi J; Okazaki K; Chiba T
    Lab Invest; 2005 Sep; 85(9):1104-17. PubMed ID: 15965489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin-1 attenuates sepsis-induced cardiomyopathy after cecal ligation and puncture in mice.
    Wilson RL; Selvaraju V; Lakshmanan R; Thirunavukkarasu M; Campbell J; McFadden DW; Maulik N
    J Surg Res; 2017 Dec; 220():68-78. PubMed ID: 29180214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice.
    Okuyama H; Nakamura H; Shimahara Y; Araya S; Kawada N; Yamaoka Y; Yodoi J
    Hepatology; 2003 May; 37(5):1015-25. PubMed ID: 12717382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span.
    Mitsui A; Hamuro J; Nakamura H; Kondo N; Hirabayashi Y; Ishizaki-Koizumi S; Hirakawa T; Inoue T; Yodoi J
    Antioxid Redox Signal; 2002 Aug; 4(4):693-6. PubMed ID: 12230882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopenia: a bone disorder associated with diabetes mellitus.
    Duarte VM; Ramos AM; Rezende LA; Macedo UB; Brandão-Neto J; Almeida MG; Rezende AA
    J Bone Miner Metab; 2005; 23(1):58-68. PubMed ID: 15616896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism.
    Umekawa T; Sugiyama T; Kihira T; Murabayashi N; Zhang L; Nagao K; Kamimoto Y; Ma N; Yodoi J; Sagawa N
    Endocrinology; 2008 Aug; 149(8):3980-8. PubMed ID: 18450962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats.
    Nakano M; Orimo N; Katagiri N; Tsubata M; Takahashi J; Van Chuyen N
    Int J Vitam Nutr Res; 2008; 78(4-5):175-82. PubMed ID: 19326340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
    Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
    Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes.
    Broulík PD; Haluzík M; Skrha J
    Physiol Res; 2003; 52(6):729-34. PubMed ID: 14640894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice.
    Pérez VI; Cortez LA; Lew CM; Rodriguez M; Webb CR; Van Remmen H; Chaudhuri A; Qi W; Lee S; Bokov A; Fok W; Jones D; Richardson A; Yodoi J; Zhang Y; Tominaga K; Hubbard GB; Ikeno Y
    J Gerontol A Biol Sci Med Sci; 2011 Dec; 66(12):1286-99. PubMed ID: 21873593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.